Skip to main content

BRIEF-Apricus Biosciences Announces Outcome Of Vitaros™ End-Of-Review Meeting With FDA

* APRICUS BIOSCIENCES ANNOUNCES OUTCOME OF VITAROS™ END-OF-REVIEW MEETING WITH FDA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.